The main risk factors for infection were receipt of corticosteroids and/or infliximab (TNF‐α targeted agent).3 Another study of 167 NSCLC patients treated with nivolumab reported that 33 infections occurred in total, of which 25 were bacterial, two were fungal and six were viral. The gene discussed is TNF; the disease is infection.